Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125736521 | 12573652 | 1 | I | 20160517 | 20160720 | 20160720 | EXP | US-STRIDES ARCOLAB LIMITED-2016SP003408 | STRIDES | 0.00 | Y | 0.00000 | 20160720 | OT | GB | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125736521 | 12573652 | 1 | PS | MYCOPHENOLATE MOFETIL. | MYCOPHENOLATE MOFETIL | 1 | UNK | U | U | 90055 | |||||||||
| 125736521 | 12573652 | 2 | SS | TACROLIMUS. | TACROLIMUS | 1 | UNK | 0 | |||||||||||
| 125736521 | 12573652 | 3 | SS | PREDNISOLONE. | PREDNISOLONE | 1 | UNK | U | U | 0 | |||||||||
| 125736521 | 12573652 | 4 | SS | IMMUNOGLOBULINS | HUMAN IMMUNOGLOBULIN G | 1 | Intravenous (not otherwise specified) | UNK | 0 | ||||||||||
| 125736521 | 12573652 | 5 | SS | THYMOGLOBULIN | LAPINE T-LYMPHOCYTE IMMUNE GLOBULIN | 1 | UNK | 0 | |||||||||||
| 125736521 | 12573652 | 6 | SS | METHYLPREDNISOLONE. | METHYLPREDNISOLONE | 1 | UNK | 0 | |||||||||||
| 125736521 | 12573652 | 7 | SS | CICLOSPORIN | CYCLOSPORINE | 1 | UNK | 0 | |||||||||||
| 125736521 | 12573652 | 8 | SS | BELATACEPT | BELATACEPT | 1 | UNK | 0 | |||||||||||
| 125736521 | 12573652 | 9 | C | SULFAMETHOXAZOLE AND TRIMETHOPRIM | SULFAMETHOXAZOLETRIMETHOPRIM | 1 | UNK | 0 | |||||||||||
| 125736521 | 12573652 | 10 | C | VALGANCICLOVIR. | VALGANCICLOVIR | 1 | UNK | 0 | |||||||||||
| 125736521 | 12573652 | 11 | C | CLOTRIMAZOLE. | CLOTRIMAZOLE | 1 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125736521 | 12573652 | 1 | Immunosuppression |
| 125736521 | 12573652 | 2 | Immunosuppression |
| 125736521 | 12573652 | 3 | Immunosuppression |
| 125736521 | 12573652 | 4 | Immunosuppression |
| 125736521 | 12573652 | 5 | Immunosuppression |
| 125736521 | 12573652 | 6 | Immunosuppression |
| 125736521 | 12573652 | 7 | Immunosuppression |
| 125736521 | 12573652 | 8 | Immunosuppression |
| 125736521 | 12573652 | 9 | Prophylaxis |
| 125736521 | 12573652 | 10 | Prophylaxis |
| 125736521 | 12573652 | 11 | Prophylaxis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125736521 | 12573652 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125736521 | 12573652 | Drug intolerance | |
| 125736521 | 12573652 | Eye infection toxoplasmal | |
| 125736521 | 12573652 | Retinal disorder | |
| 125736521 | 12573652 | Vision blurred |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |